We do not know the mechanism by which statins induce Akt1/Cav1 downregulation; nevertheless, statin-mediated attenuation of the Akt and mTOR signaling pathways has already been correlated with reduction of tumor burden in different cancers [51]. This evidence concerns the gene AKT1 and cancer.